جست‌وجوی استاد و پژوهشگر

Shana Stoddardمشاهده پروفایل

دانشیار

• Autoimmune disorders
• Protein engineering
• Computational chemistry
• +۶ مورد دیگر

Dr. Shana Stoddard is an Associate Professor of Chemistry at Rhodes College, where she leads the Molecular Immunotherapeutics Research (MIR) lab. Her research program focuses on improving patient outcomes with autoimmune disorders, cancer, neurological disorders, and coronaviruses through protein engineering, computational chemistry, and rational drug design. Dr. Stoddard received her educational training from: Postdoctoral Researcher at St. Jude Children's Research Hospital (Diagnostic Imaging) Ph.D. in Chemistry and Biochemistry from University of Mississippi M.Ed. in Curriculum and Instruction (emphasis Special Education) from Freed-Hardeman University B.S. in Chemistry from Prairie View A&M University Dr. Stoddard's research interests span multiple areas of biomedical science with a focus on therapeutic development. Her work in autoimmune disorders centers on primary membranous nephritis (PMN), where she develops auto-antibody-specific inhibitors and antigen-specific therapies. In cancer research , she focuses on designing selective histone deacetylase (HDAC) inhibitors for various cancer types, particularly targeting HDAC8 for neuroblastoma treatment. Her lab also works on neurological disorders , developing HDAC4 inhibitors for Huntington's disease and glioblastoma. During the COVID-19 pandemic, her lab pivoted to coronavirus antiviral development , creating peptide-based fusion inhibitors and protease inhibitors. Additionally, Dr. Stoddard is deeply committed to diversity and equity in STEM education , developing pedagogical approaches to create more inclusive classrooms. Analysis of Dr. Stoddard's recent publications reveals a consistent focus on structure-based drug design across multiple therapeutic areas. Her work employs computational chemistry approaches to model protein structures and design inhibitors with improved selectivity. A significant portion of her research targets histone deacetylases (HDACs), with emphasis on achieving isozyme selectivity among the 18 different HDAC enzymes. Her lab has made contributions to understanding protein structures involved in autoimmune kidney diseases and developed computational models of previously uncharacterized proteins. Dr. Stoddard has received numerous prestigious awards recognizing both her research and mentorship: 2025 – LMI Mellon Fellow 2024 – Lloyd N Ferguson Young Scientist Award from NOBCChE 2024 – Sigma Xi, The Scientific Research Honor Society inductee 2024 – Ruth Kirschstein Diversity in Science Award from ASBMB 2023 – Tyrone Mitchell Mentor-on-the-Map Award from NOBCChE 2023 – Silvia Ronco Innovative Mentor Award from CUR Chemistry 2022 – Henry C. McBay Outstanding Teaching Award from NOBCChE 2021 – Outstanding Mentor of the year Award CUR Health Sciences (Early Career Stage) 2021 – Accessibility and Inclusivity Advocate of the Year: Campus Life Award (Rhodes College) Dr. Stoddard is renowned for her exceptional mentorship of undergraduate researchers, particularly from underrepresented groups in STEM. She established the STEM Cohort Mentoring program at Rhodes in 2017 to support diverse students pursuing STEM careers. Her lab has produced numerous undergraduate co-authors on peer-reviewed publications across multiple disciplines. She has successfully guided many students into medical schools and graduate programs. Dr. Stoddard has secured competitive funding for her research, including participation in the Project Kaleidoscope STEM Leadership Institute held by the American Association of Colleges & Universities. The Molecular Immunotherapeutics Research (MIR) lab at Rhodes College is a vibrant research environment where undergraduate students work alongside Dr. Stoddard on cutting-edge biomedical research. The lab currently pursues four major research projects: 1) Protein Engineering and Development of Antigen Specific Therapeutics for Autoimmune Disorders; 2) Modeling and Investigation of Structure and Function Relationships of Unsolved Protein Structures; 3) Design, Synthesis, and Biological Testing of Novel Therapeutic Compounds for Cancer, Autoimmune, and Neurological Disorders; and 4) Development of Broad-Spectrum Coronavirus Antivirals. The MIR lab collaborates with researchers at institutions including Boston University Medical College, University of Mississippi, and St. Jude Children's Research Hospital.

• Tissue Engineering
• Biomedical Engineering
• Polymer Science
• +۳ مورد دیگر

Francesco Carfi' Pavia is a Researcher (ICHI-01/B) at the Polytechnic School of the University of Palermo . His work focuses on biomedical engineering, polymer science, and tissue engineering, particularly scaffold fabrication for 3D cell culture systems. Research Interests : His research spans scaffold design for bone and tissue regeneration, computational modeling of bioreactors, and microbial bioremediation studies. He explores advanced fabrication techniques like thermally induced phase separation (TIPS) and galvanic deposition for biomedical applications. Publications Trends : His recent articles emphasize 3D scaffold development for cancer models, orthopedic implants, and microbial adaptation to toxicants, with applications in drug delivery, tissue regeneration, and biodegradable materials. Contact : Email: francesco.carfipavia@unipa.it Office hours: Wednesdays and Thursdays, 3:00 PM–6:00 PM, Building 6, Third Floor.

Thomas Byrdمشاهده پروفایل

استادیار

• Artificial Intelligence in Healthcare
• Patient Safety and Deterioration
• Clinical Informatics
• +۳ مورد دیگر

Thomas Byrd, MD, MS, serves as Assistant Professor in the Division of Hospital Medicine within the Department of Medicine at the University of Minnesota School of Medicine. His academic work bridges clinical practice with cutting-edge informatics research, focusing on improving hospital-based care through technological innovation and data-driven approaches. Dr. Byrd's research program centers on artificial intelligence applications in surgical and critical care settings, patient deterioration detection systems, and secure clinical communication technologies. His investigations span validation of deterioration index models, barriers to secure messaging adoption, AI-driven radiology follow-up systems, and earlier work in medical imaging and biomedical engineering. This multidisciplinary focus aims to enhance patient safety through real-time monitoring, workflow optimization, and predictive analytics in hospital environments. Analysis of his 15 most recent publications (2014-2024) reveals an evolving research trajectory from biomedical engineering foundations toward AI-driven clinical solutions. Key thematic clusters include: (1) AI applications in surgery and critical care triage; (2) patient deterioration monitoring systems; (3) secure mobile communication adoption; and (4) earlier biomedical engineering work in medical imaging and drug delivery systems. The publications demonstrate increasing focus on translational informatics with strong emphasis on real-world implementation challenges. Scientific Awards: No scientific awards documented in available source material Advising and Grants: While Dr. Byrd's role as faculty suggests potential advising responsibilities, no student names or grant funding details appear in the provided documentation. His research output indicates active investigation in clinical informatics but specific mentoring activities or funded projects remain unspecified in the source text. Laboratory and Team Affiliations: Dr. Byrd is institutionally anchored in the Division of Hospital Medicine at the University of Minnesota, though specific laboratory facilities or dedicated research teams are not described. His collaborative work appears cross-disciplinary, spanning departments of medicine, surgery, radiology, and biomedical engineering as evidenced by publication topics.

Aurora Martinezمشاهده پروفایل

استاد

• Structural Biology
• Drug Discovery
• Neurometabolic Disorders
• +۷ مورد دیگر

Aurora Martinez is a Professor in the Department of Biomedicine at the University of Bergen, Faculty of Medicine. She leads the Biorecognition research group, focusing on the structural and functional aspects of biomolecules in neurometabolic disorders such as phenylketonuria (PKU) and dopamine synthesis defects. She is also a partner in the KG Jebsen Centre for Neuropsychiatric Disorders and a Toppforsk-funded project on the Arc protein, a master regulator of synaptic plasticity. Position: Professor Institution: University of Bergen Department: Department of Biomedicine Research Group: Biorecognition Email: aurora.martinez@uib.no Her research integrates structural biology, molecular recognition, and drug discovery to develop therapeutic strategies for genetic and neurodegenerative diseases. Key areas include tyrosine hydroxylase regulation, mitochondrial dysfunction in dopaminergic cells, and neurotransmitter transport mechanisms. She employs biochemical, cellular, and computational approaches to understand disease mechanisms and identify novel therapeutics. The recent publications (2023–2025) reflect a strong trend toward understanding dopamine-related pathways, protein stabilization, and therapeutic interventions in Parkinsonism and related disorders. Themes include chaperone-mediated protein stabilization, high-throughput screening for VMAT2 modulators, and computational tools for drug discovery. The work combines experimental validation with translational applications in neurodegenerative models. She has supervised multiple Master’s students, including Md. Ekhtear Mahmud, Sofie Breisnes Wormdahl, and Kristine Kippersund Brokstad, indicating active mentorship and training roles. Her involvement in large-scale collaborative projects highlights leadership and interdisciplinary engagement. While no specific awards are listed, her participation in prestigious programs like Toppforsk and the KG Jebsen Centre underscores recognition and funding success. She has no listed grants explicitly, but project affiliations suggest competitive funding support. Her research group maintains strong technical capabilities in protein analysis, cellular screening, and structural modeling. The Martinez Lab is actively involved in both fundamental and applied research, with future directions likely to expand into gene therapy, precision medicine for metabolic disorders, and neuroprotective strategies.

• Cellular & Systems Neuroscience
• Theoretical Neuroscience & Technical Applications
• Biomedical Neuroscience
• +۸ مورد دیگر

Ali Ertürk is a Professor at Helmholtz Zentrum München, serving as Director of the Institute for Tissue Engineering and Regenerative Medicine (iTERM). His work bridges cutting-edge technology and biomedical innovation, focusing on tissue clearing, spatial-omics, and AI-driven analysis to map biological systems at unprecedented resolution. His research spans three primary areas: Cellular & Systems Neuroscience Theoretical Neuroscience & Technical Applications Biomedical Neuroscience Keywords include tissue clearing, organoids, and neurodegeneration. Selected publications highlight advancements in vDISCO imaging, SHANEL protocols, and AI applications for cancer and neurodegenerative diseases. Graduated students include Dr. Chenchen Pan and Dr. Ruiyao Cai.

Tza-Huei Wangمشاهده پروفایل

استاد

• BioMEMS
• Microfluidics
• Single Molecule Detection
• +۷ مورد دیگر

Tza-Huei (Jeff) Wang is a Professor in the Department of Mechanical Engineering and holds a secondary appointment in Biomedical Engineering at Johns Hopkins University . He is also affiliated with the Sidney Kimmel Comprehensive Cancer Center and the Institute for NanoBioTechnology , driving translational research in molecular diagnostics. Doctorate in Mechanical Engineering, UCLA (2002) Wang's research focuses on micro- and nano-biotechnologies for molecular analysis and biomedical applications. His work encompasses quantum dot-FRET nanosensors for cancer biomarkers, droplet magnetofluidics for infectious disease diagnostics, and single-molecule spectroscopy platforms like CICS. These technologies address critical needs in early cancer detection , antimicrobial resistance testing , and HIV viral load self-testing . Recent publications highlight advancements in digital PCR , CRISPR-assisted diagnostics , and high-throughput antimicrobial combination screening (e.g., RoboDrop platform). His team's work on HYPER-Melt enables ultrasensitive DNA methylation analysis at 0.00005% detection thresholds. Scientific Recognition NSF CAREER Award CRS Jorge Heller Award JALA Ten Award Cohen Translational Engineering Award Fellow, AIMBE, ASME, IEEE, and RSC Wang's laboratory trains future leaders in engineering and biomedical sciences, with alumni securing faculty positions at institutions like UCSD, Penn State, and Aarhus University. His innovations have resulted in 36 patents , including 14 U.S. patents, and secured $1.5M+ IMAT R33 and $2.2M NCI R01 grants for cancer screening technologies.

• Pharmacogenetics
• Clinical Pharmacology
• Psychiatric Pharmacology
• +۳ مورد دیگر

Heshu Abdullah-Koolmees is a Lecturer at the Faculty of Science , Utrecht University , specializing in Pharmacoepidemiology and Clinical Pharmacology . With a dual appointment at Amsterdam UMC (VUmc location) , they combine academic teaching with clinical research. Academic Role : Lecturer, Faculty of Science Clinical Roles : Hospital pharmacist, Epidemiologist, Clinical pharmacologist Departments : Pharmacoepidemiology & Clinical Pharmacology Research Focus : Pharmacogenetics implementation and medication safety in psychiatric populations, particularly: Phenoconversion mechanisms in psychiatric patients Adverse drug reaction prevention Medication adherence and discontinuation patterns Management of carbamazepine intoxication Anticoagulant care during psychiatric admission Publication Trends (13+ research outputs): Recent work includes a landmark 2025 Clinical Pharmacology and Therapeutics study on pharmacogenetic implementation, high-impact Lancet publication (2023) with 176 citations, and translational research in Pharmaceutisch Weekblad (2023) about European pharmacogenetic profiling. Clinical Impact : Their research has been widely disseminated, appearing in: 420 Mendeley readers 145 news outlets 3 Wikipedia pages 4 Facebook pages

Aparna Shahمشاهده پروفایل

استادیار

• Neurobiology
• Psychiatric Disorders
• MicroRNA Regulation
• +۳ مورد دیگر

Aparna Shah is a Collegiate Assistant Professor at the School of Neuroscience, College of Science, Virginia Tech. She earned her Ph.D. in Pharmacology (Neuroscience Track) from UT Health San Antonio, a Master's in Life Sciences (Neurobiology), and a Bachelor's in Life Sciences and Biochemistry from the University of Mumbai, India. Joined Virginia Tech in 2021 Postdoctoral Fellow at Johns Hopkins University Advocate for evidence-based teaching Her research explores the neurobiology of psychiatric disorders, focusing on vagal nerve stimulation (VNS) and the microRNA-degrading enzyme translin/trax (TN/TX) complex. She investigates how VNS recruits multiple biological pathways in treatment-resistant depression and how TN/TX regulates microRNAs linked to neuronal function and synaptic plasticity. Recent publications highlight her work on adiposity, vascular stiffness, and synaptic plasticity mechanisms. She teaches courses like NEUR 2025/2026 (Intro to Neuroscience) and NEUR 3084 (Cognitive Neuroscience). Key collaborations span pharmacology, neuroscience, and cardiovascular research. Her contact: aparnashah@vt.edu .

Timothy Marlerمشاهده پروفایل

استاد

• Science, Technology, and Innovation Policy
• Emerging Technologies
• Military Technology
• +۵ مورد دیگر

Timothy Marler is a Senior Engineer and Professor of Policy Analysis at the RAND School of Public Policy, part of the RAND Corporation. His expertise spans Science, Technology, and Innovation Policy, Emerging Technologies, Military Technology, Biotechnology, Artificial Intelligence, and Optimization Modeling. He focuses on the intersection of technological advancements with global implications, emphasizing balanced policy approaches to mitigate risks while leveraging opportunities. Marler holds a Ph.D. in Mechanical Engineering from the University of Iowa, where he previously served as Assistant Director of the Virtual Soldier Research Lab, Co-Director of the Advanced Manufacturing Technology Lab, and Adjunct Professor in Biomedical, Mechanical, and Electrical Engineering. His career includes roles at Ford Motor Company, Amana, Pacific Northwest National Lab, and Hon, reflecting diverse industry experience. His research explores military training technologies, virtual reality/augmented reality, machine learning, and biotechnology. Notable projects include analyzing the U.S. Space Force's operational test infrastructure and advocating for global collaboration to address risks and opportunities from converging AI and gene-editing technologies. He currently serves on the Department of Commerce’s Materials and Equipment Technical Advisory Committee. Marler emphasizes the need for proactive policy frameworks to manage technologies like brain-computer interfaces and the metaverse, ensuring their safe and beneficial integration into society. His work bridges technical innovation with strategic policy analysis to address complex challenges in defense, public health, and global competition.

Shreyas S. Raoمشاهده پروفایل

دانشیار

• Biodegradable Polymers
• Bioengineering
• Biomaterials
• +۱۵ مورد دیگر

Dr. Shreyas S. Rao is an Associate Professor in the Department of Chemical and Biological Engineering at The University of Alabama, College of Engineering. He leads the Rao Laboratory, which is affiliated with the Polymers and Soft Materials Research Center. His research focuses on engineering 3D biomaterial scaffolds to model cancer microenvironments, particularly in metastatic breast cancer and brain metastases. Dr. Rao earned his Ph.D. and M.S. in Chemical Engineering from Ohio State University and a B.E. from R.V. College of Engineering, India. He joined The University of Alabama in 2015 after a postdoctoral position at the University of Michigan. His research interests lie at the intersection of biomaterials, cancer biology, and systems engineering. He develops hydrogel and porous scaffolds to mimic in vivo tissue conditions, enabling the study of tumor dormancy, drug resistance, and metastatic progression in physiologically relevant models. His lab integrates biomaterial design with systems biology to uncover mechanisms of therapeutic resistance and devise strategies to reprogram the tumor microenvironment. The recent publications from his lab highlight a strong focus on metastatic cancer, particularly brain metastasis in breast cancer, tumor dormancy, immune interactions, phage-based therapeutics, and biomimetic modeling. The work spans from fundamental biomaterial design to translational applications in drug screening and personalized medicine. CAREER Award, National Science Foundation, 2018 Grant recipient, Breast Cancer Research Foundation of Alabama, January 2024 Named 'Emerging Leader in Biological Engineering,' Journal of Biological Engineering, 2019 Reichhold-Shumaker Assistant Professorship, The University of Alabama, 2017 Ohio State College of Engineering’s Texnikoi Outstanding Alumni Award, 2024 National Academy of Inventors (NAI) Inductee, 2024 American Cancer Society Research Scholar Award METAvivor Early Career Investigator Award Dr. Rao has successfully advised numerous graduate and undergraduate students, many of whom have received national fellowships and awards. His research is supported by grants from the NSF, American Cancer Society, BCRFA, and METAvivor. He collaborates with researchers at institutions such as the University of Alabama at Birmingham, Ohio State University, and UNC/NCSU. The Rao Lab also engages in outreach, mentoring high school and undergraduate students through programs like Randall Research Scholars and REU. The Rao Laboratory operates within the Science and Engineering Complex and is part of a broader network of research centers including the Polymers and Soft Materials Research Center and the Integrative Center for Athletic and Sport Technology. The lab fosters interdisciplinary collaboration and innovation in bioengineering and cancer therapeutics.

Marlene Barrosمشاهده پروفایل

استاد

• Protein Chemistry
• Molecular Mechanisms of Disease
• Biomarker Discovery
• +۷ مورد دیگر

Marlene Barros is a Full Professor at the Faculty of Dental Medicine (FMD), Portuguese Catholic University (UCP), where she also serves as Director since 2020. She is the Director of the Center for Interdisciplinary Research in Health (CIIS), recognized as 'Very Good' by FCT, and leads the SalivaTec laboratory focused on saliva-based diagnostics. She has a strong academic background in biochemistry and biology, with leadership roles in education and research. Her educational qualifications include: PhD in Biochemistry (specialty: Enzymology and Protein Chemistry), University of Coimbra (1995) Agregação in Biology, University of Aveiro (2007) Marlene Barros' research is centered on protein chemistry and molecular mechanisms of disease, with a focus on identifying biomarkers for diagnosis and therapeutic targeting. Her work spans proteomics, bioinformatics, oral biology, and microbiome analysis. She has coordinated academic programs such as the Master in Molecular Microbiology and the Degree in Biomedical Sciences. Her recent research articles reflect a strong trend in salivary proteomics, oral microbiome interactions, human-viral interactomics, and the development of bioinformatics databases (e.g., OralOme, OvisOme, CanisOme). These works emphasize translational applications in precision medicine, diagnostics, and functional food science. She has received the following scientific award: Prémio Melhor Poster SciComPT 2019 She has supervised numerous academic projects and is actively involved in national and international research collaborations. She has led or participated in significant funded projects such as SPRINT, OralTherm, RedSup4Health, and OeHMP, supported by Portugal2020 and Fundación 'la Caixa'. Her work contributes to UN Sustainable Development Goals, particularly in health and education. She is a key member of the SalivaTec laboratory and contributes to interdisciplinary teams in projects involving digital health, oral microbiome, and functional foods. Her leadership extends to pedagogical innovation and community-based learning in dental education.

Donald E. Brownمشاهده پروفایل

استاد

• Data Fusion
• Knowledge Discovery
• Predictive Modeling
• +۵ مورد دیگر

Donald E. Brown is the W.S. Calcott Professor in the Systems and Information Engineering Department at the University of Virginia, serving as Founding Director of the Data Science Institute and Co-Director of the Translational Health Institute of Virginia. He holds a B.S. from the United States Military Academy (1973), M.S. and M.E. from UC Berkeley (1979), and a Ph.D. from the University of Michigan (1985). His research focuses on data fusion, knowledge discovery, and predictive modeling with applications in healthcare, security, and safety. Dr. Brown leads over 90 federal/state/private research projects, publishes extensively (120+ papers, 2 books), and is a Fellow of the IEEE. He has received prestigious awards including the Norbert Wiener Award and IEEE Millennium Medal. His work bridges academia and industry through Commonwealth Computer Research, Inc., providing data analysis services. He advises on national committees including the National Research Council and the NRC Committee on Transportation Security. His teaching excellence was recognized by students three times as 'best undergraduate teacher' (2001–2003). Research Interests: Data Fusion, Knowledge Discovery, Simulation Optimization, Machine Learning, Predictive Analytics Publications: Focus on healthcare analytics (e.g., Long COVID, tuberculosis, histopathology), AI-driven medical imaging (capsule endoscopy, eosinophil segmentation), and cybersecurity applications. Awards: IEEE Joseph Wohl Career Achievement Award (2017), Governor's Technology Award (1999), Norbert Wiener Award (2002). Grants/Projects: Over 90 funded projects on data science, healthcare tech, and security systems. He leads interdisciplinary initiatives like the iTHRIV Commons for health data sharing and develops AI tools for medical diagnostics at UVA. Current work includes AI in cardiovascular disease prediction, perioperative data digitization for LMICs, and real-time anomaly detection in healthcare systems.

• Skeletal Muscle Regeneration
• Neurovascular Tissue Regeneration
• Biomaterials for Soft Tissue Applications
• +۳ مورد دیگر

Aaron B. Morton is an Assistant Professor in Kinesiology and Sport Management at Texas A&M University, directing the Soft Tissue Regeneration and Applied Biomaterials (STRAB) Laboratory. He holds a Ph.D. in Exercise Physiology from the University of Florida (2018) and prior degrees from the University of West Florida and Harding University. His research focuses on skeletal muscle regeneration, neurovascular tissue interactions, and inorganic biomaterials for soft tissue applications, with emphasis on biomaterial development for muscle injuries and dystrophy treatment. Key research grants include a $495,972 TAMU Advancing Discovery award (2023–2025) and an NIH Loan Repayment Award for Pediatric Research (2020–2022). He has authored patents on biomaterials for stem cell dispersion and muscle treatment methods. Teaching includes KINE427 (Therapeutic Principles) and KINE433 (Exercise Physiology). Notable awards include the Microcirculatory Society Pappenheimer Postdoctoral Travel Award (2022) and multiple poster awards at physiology conferences. His work bridges biomechanical engineering with clinical applications, emphasizing translational research in regenerative therapies.

Ingunn Thoمشاهده پروفایل

استاد

• Patient-Centered Drug Formulations
• Pediatric Drug Delivery
• Mucoadhesive Buccal Films
• +۵ مورد دیگر

Ingunn Tho is a Professor at the Department of Pharmacy, University of Oslo. Her research focuses on patient-centered drug formulations, pediatric drug delivery systems, and mucoadhesive buccal films. She leads collaborative projects on nanoparticulate systems and solid dosage forms, emphasizing personalized medicine and compatibility of parenteral drugs. Key research interests include mucosal drug delivery (e.g., vaginal and buccal formulations), nanotechnology applications in drug delivery, and pharmaceutical additive manufacturing. Her work addresses challenges in pediatric care, such as dose adjustment through tablet manipulation and compatibility testing of intravenous drug mixtures. Tho has authored over 100 publications, with recent contributions on drug-polymer solubility prediction, meso-fluidic permeability assessment, and 3D-printed drug formulations. She collaborates with institutions like the Nordic Institute of Dental Materials and Åbo Akademi University. Her projects include the Nordic POP initiative and the Lumiblast research program. Her expertise spans pharmaceutical formulation design, quality-by-design principles, and in vitro evaluation methods. She is actively involved in the Controlled Release Society (CRS) Nordic Chapter and contributes to guidelines for parenteral nutrition compatibility testing.

Altuğ Mert Sevimمشاهده پروفایل

دانشیار

• Phthalocyanine Chemistry
• Dye-Sensitized Solar Cells
• Photophysical Properties
• +۵ مورد دیگر

Altuğ Mert Sevim is an Associate Professor in the Department of Chemistry at Istanbul Technical University. His research focuses on phthalocyanine chemistry, dye-sensitized solar cells (DSSCs), photodynamic therapy, and photocatalytic materials. He leads the active project Development of Phthalocyanine-Based Capacitors and Smart Clothing Application (2024–2026). His work spans over 37 publications from 2006–2025, with notable contributions to solar cell efficiency, cancer therapy, and organic-inorganic hybrid materials. Key research interests include: Design of phthalocyanine-based dyes for DSSCs Photophysical properties of novel metallophthalocyanines Applications of photosensitizers in photodynamic therapy Development of visible-light-driven photocatalysts Recent projects emphasize smart clothing applications leveraging phthalocyanine-based capacitors. Collaborations span multiple disciplines, integrating chemistry, materials science, and biomedical engineering.